Gaudet, Alexandre
Martin-Loeches, Ignacio
Povoa, Pedro
Rodriguez, Alejandro
Salluh, Jorge
Duhamel, Alain
Nseir, Saad https://orcid.org/0000-0002-7618-0357
,
Article History
Received: 21 May 2020
Accepted: 20 July 2020
First Online: 3 August 2020
Ethics approval and consent to participate
: Centers participating to the TAVeM study either received ethics approval from their institutions or ethics approval was waived (institutional review board number 2013515).
: Not applicable.
: SN reports personal fees from MSD, Pfizer, Gilead, Bio Rad, and Biomerieux, outside the submitted work; other authors have no competing interest to disclose. The authors declare that they have no competing interests.